The spread of a validated molecular marker of artemisinin partial resistance pfkelch13 R622I and association with pfhrp2/3 deletions in Eritrea
Selam Mihreteab, Karen Anderson, Irene Molina - de la Fuente, View ORCID ProfileColin J. Sutherland, David Smith, Jane Cunningham, View ORCID ProfileKhalid B Beshir, Qin Cheng
doi: https://doi.org/10.1101/2023.10.20.23297302
Selam Mihreteab
1National Malaria Control Program, Ministry of Health, Asmara, Eritrea
Karen Anderson
2Drug Resistance and Diagnostics, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia
3QIMR-Berghofer Medical Research Institute, Brisbane, Australia
Irene Molina - de la Fuente
4Carlos III Institute of Health, Madrid, Spain
5University of Alcala, Madrid, Spain
Colin J. Sutherland
6Faculty of Infectious Diseases, London School of Hygiene & Tropical Medicine, UK
David Smith
2Drug Resistance and Diagnostics, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia
3QIMR-Berghofer Medical Research Institute, Brisbane, Australia
Jane Cunningham
7Global Malaria Programme, World Health Organization, Geneva, Switzerland
Khalid B Beshir
6Faculty of Infectious Diseases, London School of Hygiene & Tropical Medicine, UK
Qin Cheng
2Drug Resistance and Diagnostics, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia
3QIMR-Berghofer Medical Research Institute, Brisbane, Australia
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 21, 2023.
The spread of a validated molecular marker of artemisinin partial resistance pfkelch13 R622I and association with pfhrp2/3 deletions in Eritrea
Selam Mihreteab, Karen Anderson, Irene Molina - de la Fuente, Colin J. Sutherland, David Smith, Jane Cunningham, Khalid B Beshir, Qin Cheng
medRxiv 2023.10.20.23297302; doi: https://doi.org/10.1101/2023.10.20.23297302
The spread of a validated molecular marker of artemisinin partial resistance pfkelch13 R622I and association with pfhrp2/3 deletions in Eritrea
Selam Mihreteab, Karen Anderson, Irene Molina - de la Fuente, Colin J. Sutherland, David Smith, Jane Cunningham, Khalid B Beshir, Qin Cheng
medRxiv 2023.10.20.23297302; doi: https://doi.org/10.1101/2023.10.20.23297302
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)